secwatch.observer — SEC 8-K summary
======================================

Issuer:     ARTELO BIOSCIENCES, INC. (ARTL)
CIK:        0001621221
Form:       8-K
Filed at:   2024-03-04T23:59:59+00:00
Accession:  0001640334-24-000345
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Artelo Biosciences reprices options to $1.55, resets vesting over 3 years for retention
--------------------------------------------------------------------------------

- Compensation Committee amends options with exercise price ≥$1.99 to new price of $1.55 (Feb 28 closing).
- New vesting: 1/3 vests on first anniversary, then 1/36 monthly; all previously unvested shares reset.
- CEO Greg Gorgas holds 274,308 option shares with original range $3.15-$39.90 affected.
- Change applies to employees and non-employee directors; no new dilution from additional grants.
- Company aims to retain key contributors while preserving cash resources.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1621221/000164033424000345/0001640334-24-000345-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1621221/000164033424000345/artl_8k.htm
  HTML page:      https://secwatch.observer/filing/0001640334-24-000345

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer